First Header Logo Second Header Logo

Connection

Anthony Atala to Cell Line, Tumor

This is a "connection" page, showing publications Anthony Atala has written about Cell Line, Tumor.
Connection Strength

2.031
  1. Kostka K, Sokolova V, El-Taibany A, Kruse B, Porada D, Wolff N, Prymak O, Seeds MC, Epple M, Atala AJ. The Application of Ultrasmall Gold Nanoparticles (2 nm) Functionalized with Doxorubicin in Three-Dimensional Normal and Glioblastoma Organoid Models of the Blood-Brain Barrier. Molecules. 2024 May 24; 29(11).
    View in: PubMed
    Score: 0.199
  2. Atala A. Re: Therapeutically Actionable PAK4 is Amplified, Overexpressed, and Involved in Bladder Cancer Progression. J Urol. 2020 09; 204(3):622-623.
    View in: PubMed
    Score: 0.152
  3. Atala A. Re: Alterations of Tumor Microenvironment by Nitric Oxide Impedes Castration-Resistant Prostate Cancer Growth. J Urol. 2019 07; 202(1):35-36.
    View in: PubMed
    Score: 0.141
  4. Atala A. Re: Classification of Prostate Cancer Using a Protease Activity Nanosensor Library. J Urol. 2019 05; 201(5):862-863.
    View in: PubMed
    Score: 0.140
  5. Atala A. Re: Mg(II)-Catechin Nanoparticles Delivering siRNA Targeting EIF5A2 Inhibit Bladder Cancer Cell Growth In Vitro and In Vivo. J Urol. 2017 08; 198(2):258-259.
    View in: PubMed
    Score: 0.122
  6. Atala A. Re: Infiltrating Macrophages Increase RCC Epithelial Mesenchymal Transition (EMT) and Stem Cell-Like Populations via AKT and mTOR Signaling. J Urol. 2017 01; 197(1):51-52.
    View in: PubMed
    Score: 0.117
  7. Atala A. Re: N-Myc Drives Neuroendocrine Prostate Cancer Initiated from Human Prostate Epithelial Cells. J Urol. 2016 11; 196(5):1584-1585.
    View in: PubMed
    Score: 0.116
  8. Atala A. Re: Regulation of UHRF1 by Dual-Strand Tumor-Suppressor MicroRNA-145 (miR-145-5p and miR-145-3p): Inhibition of Bladder Cancer Cell Aggressiveness. J Urol. 2016 10; 196(4):1314.
    View in: PubMed
    Score: 0.115
  9. Atala A. Re: Bone Metastasis in Prostate Cancer: Recurring Mitochondrial DNA Mutation Reveals Selective Pressure Exerted by the Bone Microenvironment. J Urol. 2016 09; 196(3):957-8.
    View in: PubMed
    Score: 0.115
  10. Atala A. Re: Dietary Flavonoid Fisetin Binds to ß-Tubulin and Disrupts Microtubule Dynamics in Prostate Cancer Cells. J Urol. 2016 08; 196(2):618.
    View in: PubMed
    Score: 0.114
  11. Atala A. Re: Sphaeropsidin A Shows Promising Activity against Drug-Resistant Cancer Cells by Targeting Regulatory Volume Increase. J Urol. 2016 07; 196(1):280-1.
    View in: PubMed
    Score: 0.113
  12. Atala A. Re: Infiltrating Neutrophils Promote Renal Cell Carcinoma (RCC) Proliferation via Modulating Androgen Receptor (AR)???c-Myc Signals. J Urol. 2016 06; 195(6):1947-9.
    View in: PubMed
    Score: 0.113
  13. Atala A. Re: Autophagy Defects Suggested by Low Levels of Autophagy Activator MAP1S and High Levels of Autophagy Inhibitor LRPPRC Predict Poor Prognosis of Prostate Cancer Patients. J Urol. 2016 06; 195(6):1948-9.
    View in: PubMed
    Score: 0.113
  14. Atala A. Re: Tumour-Suppressive MicroRNA-29s Directly Regulate LOXL2 Expression and Inhibit Cancer Cell Migration and Invasion in Renal Cell Carcinoma. J Urol. 2016 May; 195(5):1622.
    View in: PubMed
    Score: 0.112
  15. Atala A. Re: Human Schlafen 5 (SLFN5) is a Regulator of Motility and Invasiveness of Renal Cell Carcinoma Cells. J Urol. 2016 04; 195(4 Pt 1):1169.
    View in: PubMed
    Score: 0.112
  16. Rajan SAP, Aleman J, Wan M, Pourhabibi Zarandi N, Nzou G, Murphy S, Bishop CE, Sadri-Ardekani H, Shupe T, Atala A, Hall AR, Skardal A. Probing prodrug metabolism and reciprocal toxicity with an integrated and humanized multi-tissue organ-on-a-chip platform. Acta Biomater. 2020 04 01; 106:124-135.
    View in: PubMed
    Score: 0.037
  17. Peak TC, Praharaj PP, Panigrahi GK, Doyle M, Su Y, Schlaepfer IR, Singh R, Vander Griend DJ, Alickson J, Hemal A, Atala A, Deep G. Exosomes secreted by placental stem cells selectively inhibit growth of aggressive prostate cancer cells. Biochem Biophys Res Commun. 2018 05 23; 499(4):1004-1010.
    View in: PubMed
    Score: 0.033
  18. Skardal A, Devarasetty M, Forsythe S, Atala A, Soker S. A reductionist metastasis-on-a-chip platform for in vitro tumor progression modeling and drug screening. Biotechnol Bioeng. 2016 09; 113(9):2020-32.
    View in: PubMed
    Score: 0.028
  19. Marcus K, Johnson M, Adam RM, O'Reilly MS, Donovan M, Atala A, Freeman MR, Soker S. Tumor cell-associated neuropilin-1 and vascular endothelial growth factor expression as determinants of tumor growth in neuroblastoma. Neuropathology. 2005 Sep; 25(3):178-87.
    View in: PubMed
    Score: 0.014
  20. Mukherjee P, Bhattacharya R, Wang P, Wang L, Basu S, Nagy JA, Atala A, Mukhopadhyay D, Soker S. Antiangiogenic properties of gold nanoparticles. Clin Cancer Res. 2005 May 01; 11(9):3530-4.
    View in: PubMed
    Score: 0.013
  21. Doherty SC, McKeown SR, McKelvey-Martin V, Downes CS, Atala A, Yoo JJ, Simpson DA, Kaufmann WK. Cell cycle checkpoint function in bladder cancer. J Natl Cancer Inst. 2003 Dec 17; 95(24):1859-68.
    View in: PubMed
    Score: 0.012
Connection Strength

The connection strength for concepts is the sum of the scores for each matching publication.

Publication scores are based on many factors, including how long ago they were written and whether the person is a first or senior author.